Dr. Rodriguez Valdes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Summary
- I am a myeloma specialist in charge of clinical and transactional research for the Myeloma Program at Wake Forest University. I do clinical care including stem cell transplants and cell therapy. My translational research focus is on myeloma organoids to understand chemoresistance.
Education & Training
- University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
- Texas Tech University HSC El PasoResidency, Internal Medicine, 2006 - 2009
- Monterrey Inst TechClass of 2005
- ITESM MD
Certifications & Licensure
- FL State Medical License 2022 - Present
- NY State Medical License 2021 - 2026
- NC State Medical License 2015 - 2021
- KY State Medical License 2009 - 2016
- SC State Medical License 2008 - 2013
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top 40 under 40 Business Insider, 2015
- National Patient's Choice Award 2014
- Leukemia and Lymphoma Society Man of the Year LLS, 2014
- Join now to see all
Clinical Trials
- A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) Start of enrollment: 2008 Jan 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 77 citationsStandardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori
Transplantation and Cellular Therapy. 2021-08-01 - 384 citationsDaratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves
Blood. 2020-08-20 - 17 citationsSequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, Jeanne Li, Yogita Ghodke-Puranik
Blood Advances. 2023-03-28
Journal Articles
- KLF9-dependent ROS regulate melanoma progression in stage-specific MannerM Nikiforov, A Bagati, S Moparthy, E Fink, A Bianchi-Smiraglia, D Yun, M Kolesnikova, O Udartseva, D Wolff, M Roll, B Lipchik, N Kozlova, P Jowdy, A Berman, N Box, ES ..., Oncogene, 1/21/2019
- Paraproteinemia and serum protein electrophoresis interpretationSK Raj, B Guha, C Rodriguez, B Krishnaswamy, Ann Allrgy Asthma Immunol, 1/1/2019
- Guidance from ASMBT Practice Guidelines Committee for establishing a long term follow-up clinic for hematopoietic cell transplant survivorsSK Hashmi, SJ Lee, BN Savani, L Burns, JR Wingard, MA Perales, J Palmer, E Chow, E Meyer, D Marks, M Mohty, Y Inamoto, C Rodriguez, JD Rizzo, PA Carpenter, BBMT, 1/30/2018
- Join now to see all
Abstracts/Posters
- Model of patient-specific multiple myeloma 3D printed organodis for predicting chemotherapy response: feasibility Study.J Aleman, A Maycock, S George, C Porada, G Almeida-Porada, C Rodriguez, A Skardal, NCTERMS, 1/23/2019
- Assessment of treatment-related effects on cognition in multiple myeloma patients undergoing autologous stem cell transplant.*M Tam, E Dressler, K Duckworth, C Rodriguez, Women�s Health Research Day, 1/17/2019
- Tacrolimus levels and correlation to age and weight calculation.Seegars MB, Isom S, Kennedy L, Anders B, Rodriguez C, ASBMT Oral and Poster Session II, Salt Lake City, 2/24/2018
- Join now to see all
Lectures
- Emerging Small Molecules in Multiple MyelomaAtrium Health, Charlotte, NC - 1/11/2019
- Insights into Managing MyelomaCary, NC - 1/7/2019
- MNI Great Lakes Bone Health ECHO, Paraprotein Screening in Osteoporosis PatientsMichigan - 1/27/2018
- Join now to see all
Other
- (Featured article) Featured article on the research I am doing regarding 3D myeloma cultures.Valdes CR, MD Anderson: The Multiple Myeloma Daily
1/23/2019 - Report on immunotherapy for myeloma treatment using first-in-human BiTE clinical trials at Wake Forest.Valdes CR, WXII News
1/22/2018 - (Featured documentary) Participated on a documentary focused on myeloma awareness and the milestones in treatment thanks to ongoing research.Valdes CR, Cures Magazine
1/9/2018 - Join now to see all
Press Mentions
- International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific AssemblyAugust 15th, 2024
Grant Support
- Young InvestigatorCTSIPresent
- Translational Research in MyelomaMyeloma Crowd Research InitiativePresent
Committees
- member, CTN MRD and immune profiling 2016 - Present
- member, CTN myeloma committee 2015 - Present
- member, ASBMT Practice Guidelines 2015 - Present
Research History
- Multiple Myeloma and Plasma Cell Disorders Lead2015 - Present
Professional Memberships
- Member
- Member
Other Languages
- French, Italian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: